Tag Archives: Patents

MSF responds to European approval of hepatitis C drug daclatasvir

On 27 August 2014, the European Commission (EC) and the European MedicinesAgency (EMA) became the second stringent regulatory authority (after Japanin July) to approve new direct-acting antiviral (DAA) daclatasvir, used totreat hepatitis C. Daclatasvir is the third DAA – a … Continue reading

Posted in Hepatitis C, Price Negotiations, Right to Health | Tagged , , , , , , | Leave a comment

WSJ: India Plans Price Controls for Patented Drugs

India Plans Price Controls for Patented Drugs By RUMMAN AHMED BANGALORE–An Indian government panel Wednesday published a set of proposals to control the prices of patented drugs, a plan which has drawn fire from the pharmaceutical industry. If implemented, the proposals … Continue reading

Posted in Compulsory Licensing | Tagged , | 1 Comment